Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 1/20 | 0.55 |
| ▸ | TACR1 | P25103 | 1/20 | 0.55 |
| ▸ | TACR3 | P29371 | 1/20 | 0.55 |
| ▸ | CXCR4 | P61073 | 6/20 | 0.55 |
| ▸ | CCR5 | P51681 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.49 |
| ▸ | DRD2 | P14416 | 2/20 | 0.49 |
| ▸ | HTR2A | P28223 | 1/20 | 0.49 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | HTR2B | P41595 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3597889 | 0.90 | CCR5 (0.57) | CXCR4CCR5POLBALDH1A1ATM | |
| SCHEMBL19658975 | 0.87 | CCR5 (0.58) | CXCR4CCR5POLBALDH1A1ATM | |
| SCHEMBL19652145 | 0.87 | CCR5 (0.55) | CXCR4CCR5POLBALDH1A1ATM | |
| SCHEMBL28003062 | 0.85 | ACHE (0.58) | CXCR4ALDH1A1ATMSIGMAR1DRD2 | |
| SCHEMBL19658602 | 0.85 | CXCR4 (0.59) | CXCR4POLBALDH1A1ATMDRD2 | |
| SCHEMBL19658477 | 0.84 | CCR5 (0.55) | CCR5POLBALDH1A1ATMSIGMAR1 | |
| SCHEMBL9030647 | 0.83 | SIGMAR1 (0.67) | SIGMAR1DRD2HTR2AHTR2CHTR2B | |
| SCHEMBL17753689 | 0.83 | CXCR4 (0.63) | CXCR4POLBALDH1A1ATMSIGMAR1 | |
| SCHEMBL28910476 | 0.82 | CXCR4 (0.61) | CXCR4POLBALDH1A1ATMSIGMAR1 | |
| SCHEMBL19658471 | 0.81 | NOS3 (0.48) | CCR5ALDH1A1SIGMAR1DRD2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170340604-A1 | THERAPEUTIC COMPOUNDS AND USES THEREOF | GENENTECH, INC. (US) | 2017-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170340604-A1 | THERAPEUTIC COMPOUNDS AND USES THEREOF | BRD4, BRDT, BRD3 | TACR2 1088/4885TACR1 1800/4885TACR3 2593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.